Back to Agenda
International Coalition of Medicines Regulatory Authorities (ICMRA): Harnessing Achievements During COVID-19 for the Future
Session Chair(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs, European Medicines Agency, Netherlands
There is an on-going need for coordination, ownership, and oversight of the various changes, improvements, and flexibilities that have emerged through the pandemic. While this is a multipronged problem, the regulatory coordination, flexibility and speed are paramount. ICMRA and their achievements that were the most visible during COVID-19 will be discussed including global regulatory collaboration and its impact during the pandemic. Additionally, a panel discussion on the role of ICMRA for the future of convergence, and the impact of achievements during COVID-19 on its strategic initiatives and technical workstreams will be included.
Learning Objective : Identify the role and activities of ICMRA; Discuss the collaboration within ICMRA during COVID-19; Describe ICMRA achievements beyond COVID-19.
Speaker(s)
How Regulatory Cooperation and Convergence has Helped COVID Vaccines Gain Authorization Globally
Charbel Haber, PhD, MBA, MPH
Senior Vice President, Head of Regulatory Affairs, Moderna, United States
COVID-19 Experience and How ICMRA’s Efforts Supported Development of Vaccines and Therapeutics
Sean Curtis, MD, MPH
Senior Vice President, Global Regulatory Affairs and Clinical Safety, Merck, United States
ICMRA’s Achievements from the Perspective of NiFDS
Kyung Won Seo
Director General, National Institute of Food and Drug Safety Evaluation, Ministiry of Food and Drug Safety, Korea, Republic of
ICMRA Vaccine Pharmacovigilance
John Skerritt, PhD
Enterprise Professor, Health Research Impact, University of Melbourne, Australia
ICMRA's Achievements From ANVISA's Perspective
Antonio Barra Torres, MD
President Director, ANVISA, Brazil
ICMRA's Achievements From EMA's Perspective
Emer Cooke, MBA
Executive Director, European Medicines Agency, Netherlands
ICMRA's Achievements From Health Canada's Perspective
Pierre Sabourin, MBA
Assistant Deputy Minister, Health Products and Food Branch, Health Canada, Canada
Have an account?